Advertisement

Topics

Conversations with Patient Advocates: Ron Hollander, president of INCA

10:37 EST 9 Nov 2017 | Novartis

We believe we can make a greater difference through collaboration. That is why we are excited to introduce a new series – called “Novartis Connects: Conversations with Patient Advocates” – that will showcase stories from many of the patient advocacy groups working with Novartis. These organizations are helping us connect with the cancer community on a more personal level so we can better understand and meet patients’ needs. 

...

Original Article: Conversations with Patient Advocates: Ron Hollander, president of INCA

NEXT ARTICLE

More From BioPortfolio on "Conversations with Patient Advocates: Ron Hollander, president of INCA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...